These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 11464891

  • 1. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
    Cheung NK, Kushner BH, LaQuaglia M, Kramer K, Gollamudi S, Heller G, Gerald W, Yeh S, Finn R, Larson SM, Wuest D, Byrnes M, Dantis E, Mora J, Cheung IY, Rosenfield N, Abramson S, O'Reilly RJ.
    Med Pediatr Oncol; 2001 Jan; 36(1):227-30. PubMed ID: 11464891
    [Abstract] [Full Text] [Related]

  • 2. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K, Fukuda M, Miyajima Y, Matsumoto K, Kondo M, Inaba J, Miyashita Y.
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [Abstract] [Full Text] [Related]

  • 3. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
    Kushner BH, Cheung IY, Kramer K, Modak S, Cheung NK.
    Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906
    [Abstract] [Full Text] [Related]

  • 4. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique.
    Rubie H, Plantaz D, Coze C, Michon J, Frappaz D, Baranzelli MC, Chastagner P, Peyroulet MC, Hartmann O, Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique.
    Med Pediatr Oncol; 2001 Jan; 36(1):247-50. PubMed ID: 11464897
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF, Liu DG, Su YS, Lin TY, Chen XQ, He YJ.
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [Abstract] [Full Text] [Related]

  • 6. Neuroblastoma.
    Meir HM, Balawi I, Nayel H, Yousef MK, Badawood S, Al-Mobarak M.
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [Abstract] [Full Text] [Related]

  • 7. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.
    Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK.
    J Clin Oncol; 2004 Dec 15; 22(24):4888-92. PubMed ID: 15611504
    [Abstract] [Full Text] [Related]

  • 8. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.
    Kushner BH, LaQuaglia MP, Bonilla MA, Lindsley K, Rosenfield N, Yeh S, Eddy J, Gerald WL, Heller G, Cheung NK.
    J Clin Oncol; 1994 Dec 15; 12(12):2607-13. PubMed ID: 7527454
    [Abstract] [Full Text] [Related]

  • 9. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Dec 15; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 10. Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience.
    Kushner BH, Kramer K, LaQuaglia MP, Modak S, Cheung NK.
    Med Pediatr Oncol; 2003 Dec 15; 41(6):508-15. PubMed ID: 14595707
    [Abstract] [Full Text] [Related]

  • 11. A novel intensive induction therapy for high-risk neuroblastoma utilizing sequential peripheral blood stem cell collection and infusion as hematopoietic support.
    Pradhan KR, Johnson CS, Vik TA, Sender LS, Kreissman SG.
    Pediatr Blood Cancer; 2006 Jun 15; 46(7):793-802. PubMed ID: 16206215
    [Abstract] [Full Text] [Related]

  • 12. Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
    Cheung NK, Guo HF, Heller G, Cheung IY.
    Clin Cancer Res; 2000 Jul 15; 6(7):2653-60. PubMed ID: 10914706
    [Abstract] [Full Text] [Related]

  • 13. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS, Felgenhauer J, Park J, Kreissman S, Thomson B, Douglas J, Rowley SD, Gooley T, Sanders JE, Pendergrass TW.
    Cancer; 2002 Sep 15; 95(6):1354-65. PubMed ID: 12216105
    [Abstract] [Full Text] [Related]

  • 14. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
    Valteau-Couanet D, Vassal G, Pondarré C, Bonnay M, Benhamou E, Couanet D, Plantaz D, Hartmann O.
    Bone Marrow Transplant; 1996 Apr 15; 17(4):485-9. PubMed ID: 8722343
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma.
    Kuroda T, Morikawa N, Matsuoka K, Fujino A, Honna T, Nakagawa A, Kumagai M, Masaki H, Saeki M.
    J Pediatr Surg; 2008 Dec 15; 43(12):2182-5. PubMed ID: 19040931
    [Abstract] [Full Text] [Related]

  • 16. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S, Tornesello A, Diociaiuti L, Pession A, Prete A, Rufini V, Troncone L, Mastrangelo R.
    Br J Cancer; 2001 Feb 15; 84(4):460-4. PubMed ID: 11207038
    [Abstract] [Full Text] [Related]

  • 17. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML, Lal A, Seeger RC, Maris JM, Shimada H, O'Leary M, Gerbing RB, Matthay KK.
    J Clin Oncol; 2005 Sep 20; 23(27):6474-80. PubMed ID: 16116154
    [Abstract] [Full Text] [Related]

  • 18. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F, Santana VM, Billups CA, Merchant TE, Furman WL, Spunt SL, Cain AM, Rao BN, Hale GA, Pappo AS.
    Cancer; 2006 Apr 15; 106(8):1846-56. PubMed ID: 16541446
    [Abstract] [Full Text] [Related]

  • 19. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1358-63. PubMed ID: 19019566
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.